The expression level of NKG2D on intrahepatic CD56bright NK cells was also significantly higher in liver from NAFLD patients compared with normal liver (Supplementary Figure 5), as reported for HBV- and HCV-infected patients (40). This evidence concerns the gene KLRK1 and metabolic dysfunction-associated steatotic liver disease.